End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.26 PLN | -5.80% |
|
-7.47% | -24.42% |
May. 15 | MedApp S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Feb. 14 | MedApp S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 94.18 | 200.3 | 245.9 | 235.1 | 97.55 | 86.05 |
Enterprise Value (EV) 1 | 93.45 | 200.3 | 245.1 | 235 | 97.81 | 87.87 |
P/E ratio | -39.8 x | 298 x | 130 x | 61.7 x | 163 x | -26.5 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 761 x | 62.1 x | 40.8 x | 18.5 x | 14.5 x | 15 x |
EV / Revenue | 755 x | 62.1 x | 40.7 x | 18.5 x | 14.5 x | 15.3 x |
EV / EBITDA | -60.4 x | 225 x | 95.9 x | 40.7 x | 31.8 x | 21.4 x |
EV / FCF | -76.2 x | -21.4 x | 108 x | -215 x | -95.1 x | 221 x |
FCF Yield | -1.31% | -4.67% | 0.93% | -0.46% | -1.05% | 0.45% |
Price to Book | 16.4 x | 12.3 x | 12.1 x | 9.64 x | 3.59 x | 3.58 x |
Nbr of stocks (in thousands) | 138,500 | 237,089 | 247,161 | 250,132 | 250,132 | 250,132 |
Reference price 2 | 0.6800 | 0.8450 | 0.9950 | 0.9400 | 0.3900 | 0.3440 |
Announcement Date | 5/31/19 | 6/30/20 | 3/22/21 | 4/29/22 | 5/31/23 | 6/28/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 0.1238 | 3.226 | 6.025 | 12.71 | 6.733 | 5.735 |
EBITDA 1 | -1.548 | 0.8904 | 2.557 | 5.777 | 3.078 | 4.101 |
EBIT 1 | -1.945 | 0.5485 | 2.116 | 5.28 | 1.28 | -0.69 |
Operating Margin | -1,571.32% | 17% | 35.12% | 41.55% | 19.01% | -12.03% |
Earnings before Tax (EBT) 1 | -2.006 | 0.4698 | 1.874 | 4.112 | 1.199 | -2.829 |
Net income 1 | -2.365 | 0.6731 | 1.915 | 3.813 | 0.609 | -3.151 |
Net margin | -1,910.59% | 20.87% | 31.79% | 30% | 9.05% | -54.94% |
EPS 2 | -0.0171 | 0.002839 | 0.007659 | 0.0152 | 0.002400 | -0.0130 |
Free Cash Flow 1 | -1.227 | -9.354 | 2.268 | -1.091 | -1.029 | 0.3974 |
FCF margin | -991.13% | -289.95% | 37.64% | -8.58% | -15.28% | 6.93% |
FCF Conversion (EBITDA) | - | - | 88.71% | - | - | 9.69% |
FCF Conversion (Net income) | - | - | 118.42% | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 5/31/19 | 6/30/20 | 3/22/21 | 4/29/22 | 5/31/23 | 6/28/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | 0.26 | 1.83 |
Net Cash position 1 | 0.73 | 0.07 | 0.78 | 0.13 | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | 0.0841 x | 0.445 x |
Free Cash Flow 1 | -1.23 | -9.35 | 2.27 | -1.09 | -1.03 | 0.4 |
ROE (net income / shareholders' equity) | -40% | 6.13% | 10.4% | 17% | 2.27% | -11.6% |
ROA (Net income/ Total Assets) | -10.7% | 2.17% | 6.3% | 12.5% | 2.48% | -1.27% |
Assets 1 | 22.18 | 31.03 | 30.4 | 30.47 | 24.6 | 247.9 |
Book Value Per Share 2 | 0.0400 | 0.0700 | 0.0800 | 0.1000 | 0.1100 | 0.1000 |
Cash Flow per Share 2 | 0 | 0 | 0 | 0 | 0 | 0 |
Capex 1 | 0.07 | - | 0.11 | 0.24 | 6.52 | - |
Capex / Sales | 60.29% | - | 1.91% | 1.89% | 96.79% | - |
Announcement Date | 5/31/19 | 6/30/20 | 3/22/21 | 4/29/22 | 5/31/23 | 6/28/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.42% | 16.61M | |
-6.53% | 247B | |
-17.84% | 60.17B | |
+1.97% | 59.51B | |
+2.17% | 53.61B | |
+4.79% | 42.54B | |
+6.21% | 38.61B | |
-9.81% | 28.57B | |
+105.80% | 26.98B | |
+2.75% | 21.53B |
- Stock Market
- Equities
- MDA Stock
- Financials MedApp S.A.